The effect of nifedipine on serum endothelin-1 levels in essential hypertension. 1997

T Akpolat, and M Başkol, and B Adam, and N Arik, and A Bedir

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000286 Administration, Sublingual Administration of a soluble dosage form by placement under the tongue. Drug Administration, Sublingual,Sublingual Drug Administration,Sublingual Administration,Administration, Sublingual Drug,Administrations, Sublingual,Administrations, Sublingual Drug,Drug Administrations, Sublingual,Sublingual Administrations,Sublingual Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D019332 Endothelin-1 A 21-amino acid peptide produced in a variety of tissues including endothelial and vascular smooth-muscle cells, neurons and astrocytes in the central nervous system, and endometrial cells. It acts as a modulator of vasomotor tone, cell proliferation, and hormone production. (N Eng J Med 1995;333(6):356-63) Big Endothelin,Big Endothelin-1,Endothelin Type 1,Endothelin, Big,Preproendothelin,Preproendothelin-1,Proendothelin (1-38),Proendothelin-1 Precursor,Big Endothelin 1,Endothelin 1,Endothelin-1, Big,Precursor, Proendothelin-1,Preproendothelin 1,Proendothelin 1 Precursor

Related Publications

T Akpolat, and M Başkol, and B Adam, and N Arik, and A Bedir
October 2021, Pathophysiology : the official journal of the International Society for Pathophysiology,
T Akpolat, and M Başkol, and B Adam, and N Arik, and A Bedir
February 2007, Hypertension (Dallas, Tex. : 1979),
T Akpolat, and M Başkol, and B Adam, and N Arik, and A Bedir
August 1996, Orvosi hetilap,
T Akpolat, and M Başkol, and B Adam, and N Arik, and A Bedir
November 1996, American heart journal,
T Akpolat, and M Başkol, and B Adam, and N Arik, and A Bedir
November 1987, Medicina clinica,
T Akpolat, and M Başkol, and B Adam, and N Arik, and A Bedir
August 1986, Hypertension (Dallas, Tex. : 1979),
T Akpolat, and M Başkol, and B Adam, and N Arik, and A Bedir
July 1986, International journal of clinical pharmacology, therapy, and toxicology,
T Akpolat, and M Başkol, and B Adam, and N Arik, and A Bedir
February 1998, Hypertension (Dallas, Tex. : 1979),
T Akpolat, and M Başkol, and B Adam, and N Arik, and A Bedir
May 1988, Hypertension (Dallas, Tex. : 1979),
T Akpolat, and M Başkol, and B Adam, and N Arik, and A Bedir
January 2013, Clinical and experimental hypertension (New York, N.Y. : 1993),
Copied contents to your clipboard!